Equity Research, Broker Reports, and media content on AstraZeneca PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

AstraZeneca PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca PLC. We currently have 190 research reports from 11 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 5871/10120p
  • Daily Volume: N/A
  • Daily Liquidity: (0.41%)
  • # Shares: 1,312m
  • Market Cap: £102,189m
  • Latest PE (hist): 54.80
  • Div Yield: 3.83
Date Source Announcement
23Nov20 07:00 RNS AZD1222 vaccine effective against COVID-19
20Nov20 07:00 RNS Imfinzi new dosing approved in the US
10Nov20 07:00 RNS Tezepelumab Phase III trial met primary endpoint
09Nov20 07:00 RNS Calquence approved in the EU for CLL
06Nov20 07:00 RNS Brilinta approved in the US in stroke
05Nov20 07:15 RNS Lynparza approved in the EU for wider ovarian use
05Nov20 07:10 RNS Lynparza approved in the EU for prostate cancer
  • Frequency of research reports

     

  • Research reports on

    AstraZeneca PLC

  • Providers covering

    AstraZeneca PLC